Faecal inflammatory markers after bariatric surgery

Faecal inflammatory markers after bariatric surgery - nvt

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42770

Enrollment

Registered

2016-01-13

Start date

2016-10-03

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric bypass

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who will undergo either a RYGB or sleeve gastrectomy.

Exclusion criteria

Exclusion criteria: - Diarrhea at the time of faeces collection - Useage of NSAID and unable tot stop for at least 5 days prior to faeces collection. - Unable to fill out questionares because of linguistic difficulties - An acute gastrointestinal disease at the time of participation or chronic gastrointestinal disease in the medical history

Design outcomes

Primary

Measure	Time frame
Primary outcome is the concentration and progression over time of the faecal inflammatory markers calprotectin, lactoferrin and calgranulin C, before and until 1 year after RYGB.	—

Secondary

Measure	Time frame
Secondary outcomes - Secondary outcome is the difference between concentrations of calprotectin, lactoferrin and calgranulin-C after RYGB or sleeve gastrectomy - Another outcome is the correlation between GSRS scores and concentration of faecal inflammatory markers after bariatric surgery	—

Countries

Netherlands

Outcome results